Important Safety Information For Patients

Do not take KAPVAY® if you are allergic to clonidine.

● Use KAPVAY® with caution if you have high or low blood pressure, kidney problems, or heart problems, including heart attacks or strokes. You should avoid becoming dehydrated or overheated when taking KAPVAY®

Safety Information Continued Below

Patient Support
A diagnosis of ADHD in childhood is very common. By 2007, approximately 5.4 million children had already been diagnosed with ADHD...and the prevalence of ADHD has continued to rise each year.

This site and these resources do not take the place of talking to a doctor about your child’s medical condition or treatment.
Finding additional ADHD resources
Since ADHD affects such a large population, there are many resources now available to help you and your child. The following Web sites offer advice, and many list live support groups in your local area.

CHADD
http://www.chadd.org/

A Guide to Raising Children With ADHD
http://www.adhdchildparenting.com/

National Resource Center on ADHD
www.help4adhd.org

American Academy of Child & Adolescent Psychiatry (AACAP)
www.aacap.org/cs/ADHD.ResourceCenter

National Institute of Mental Health
http://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd/index.shtml








KAPVAY® is a registered trademark of
Concordia Pharmaceuticals Inc.
©2013 Concordia Pharmaceuticals Inc.
Bridgetown, Barbados, BB11128

All rights reserved.
Privacy Policy | Terms of Use
Contact Concordia Pharmaceuticals Inc.
For medical inquires, call 1-877-370-1142.
KAP-WWW-001 10/13
 
This website and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.